RETATRUTIDE PEN

Retatrutide (LY-3437943)

Retatrutide is a triple-agonist peptide that simultaneously acts on:

• GLP-1 receptors
• GIP receptors
• Glucagon receptors

This unique combination is central in international scientific research on:

• Energy balance
• Metabolic regulation
• Glucose homeostasis
• Incretin synergy and fat oxidation

Research Findings:
In phase-2 studies by Eli Lilly, published in The New England Journal of Medicine (2023), participants experienced an average weight reduction of 17–24% over 24–48 weeks, depending on dose and study design.
Improvements were also observed in metabolic markers, including HbA1c reductions in models of type 2 diabetes.
Further studies focus on long-term mechanisms and safety of combined incretin agonists.

Included in Each Order:
Each order contains a complete research kit:

• ✓ Retatrutide Pen – 60 mg (pre-reconstituted)
• ✓ 4× sterile 32G – 4 mm needles
• ✓ Alcohol wipes

Why Choose the Retatrutide Pen:

• ✓ Ready for immediate laboratory use
• ✓ No reconstitution required
• ✓ Consistent concentration & reproducible results
• ✓ Suitable for controlled research protocols
• ✓ Available in multiple dosages

Storage & Shipping:

• Store refrigerated immediately upon receipt according to lab guidelines
• Product delivered within 24 hours to ensure stability
• Sale and delivery limited to the Netherlands

Application & Use (Research Only):

• Developed for in-vitro research purposes
• Not intended for medical, therapeutic, or diagnostic use
• Use only within a controlled research environment

Legal Notice:

• For laboratory research only
• Not intended for human or animal consumption or injection
• Not approved as a drug or medical product

• Buyers are responsible for compliance with local laws and regulations
• Seller is not liable for improper or unauthorized use